South Asian Patient Population Genetics Reveal Strong Founder Effects and High Rates of Homozygosity – New Resources for Precision Medicine
Jeffrey D Wall,
J. Fah Sathirapongsasuti,
Rajesh Kumar Rai,
Santosh Gopi Krishna Gadde,
B. V. Priya,
Naveen Kumar Naik,
Amit V Khera,
B. R. Lakshmi,
Andrew S. Peterson
Posted 02 Oct 2020
bioRxiv DOI: 10.1101/2020.10.02.323238
Posted 02 Oct 2020
Population-scale genetic studies can identify drug targets and allow disease risk to be predicted with resulting benefit for management of individual health risks and system-wide allocation of health care delivery resources. Although population-scale projects are underway in many parts of the world, genetic variation between population groups means that additional projects are warranted. South Asia has a population whose genetics is the least characterized of any of the world’s major populations. Here we describe GenomeAsia studies that characterize population structure in South Asia and that create tools for economical and accurate genotyping at population-scale. Prior work on population structure characterized isolated population groups, the relevance of which to large-scale studies of disease genetics is unclear. For our studies we used whole genome sequence information from 4,807 individuals recruited in the health care delivery systems of Pakistan, India and Bangladesh to ensure relevance to population-scale studies of disease genetics. We combined this with WGS data from 927 individuals from isolated South Asian population groups, and developed a custom SNP array (called SARGAM) that is optimized for future human genetic studies in South Asia. We find evidence for high rates of reproductive isolation, endogamy and consanguinity that vary across the subcontinent and that lead to levels of homozygosity that approach 100 times that seen in outbred populations. We describe founder effects that increase the power to associate functional variants with disease processes and that make South Asia a uniquely powerful place for population-scale genetic studies. ### Competing Interest Statement J. F. Sathirapongsasuti is an employee of MedGenome and a former employee of 23andMe. A. S. Peterson and E. Stawiski are former employees of MedGenome and Genentech. J. D. Wall is a consultant for MedGenome. R. Menon, S. Phalke, D. Tanneeru, R. Chaudhary and R. Gupta are employees of MedGenome. Q. Bei, T. Bhangale and J. Tom are employees of Genentech. A. Mittal and J. Fang are employees of Thermo Fisher Scientific.
- Downloaded 692 times
- Download rankings, all-time:
- Site-wide: 33,126
- In genomics: 2,946
- Year to date:
- Site-wide: 11,208
- Since beginning of last month:
- Site-wide: 6,852
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!